Pharmanovia A/S: Financial statements 2024
CVR: 32287824
Source: annual report 2024, Danish Business Authority
01/04/2023 – 31/03/2024
Pharmanovia A/S (CVR 32287824) has filed annual accounts for 2024. In 2024, the company reported a gross profit of EUR 4,683,828 and a net result of EUR 2,246,626 compared with DKK 26,130,781 the year before. That is a decrease of 89.4% compared with the year before. Equity in the 2024 report amounted to EUR 4,883,410. The solvency ratio was 10.2%. The company had 12 employees in the financial year.
- Gross Profit
- EUR 4,683,828
- Profit/Loss
- EUR 2,246,626
- Equity
- EUR 4,883,410
- Total Assets
- EUR 47,727,518
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 4.7M EUR | 2.2M EUR | 4.9M EUR | 12 |
| 2023 | - | 44M | 26.1M | 19.6M | 15 |
| 2022 | - | 3.4M | -21.6M | -6.5M | 18 |
| 2021 | - | 15.2M | -2M | 15.1M | 15 |
| 2020 | - | 3.7M | -13.7M | 17.1M | 12 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Pharmanovia A/S has won the tender "Amgros 2024 1.1219.a" issued by Amgros I/S worth 2,340,000 DKK.
About Pharmanovia A/S
Pharmanovia A/S is a Danish company of the type Aktieselskab based in København S, founded in 2009. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Atnahs Pharma Nordics A/S and PHARMANOVIA A/S. The management consists of Christoph Michael Habereder. The board consists of Mohammad Muqtadir Samy (chair), Christoph Michael Habereder and Twan Johannes Anna Nouwen. The company is owned by Atnahs Pharma UK Limited. The company has 3 employees (2026). In 2026, the company reported a gross profit of EUR 11,734,813 and a net result of EUR 7,730,657 compared with DKK 3,839,334 the year before. Equity in the 2026 report amounted to EUR 15,820,601.